Gaurang Gandhi, MD
Clinical Cardiac Electrophysiology · Cincinnati, OHNPI 1770574832
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (44.7%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Medtronic at 25.1% of the total. 2025 is the largest year on record at $63,592, 3.7 times the $17,349 reported in 2019. Among clinical cardiac electrophysiology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 656 payments — averaging $272.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$45K
- Boston Scientific$44K
- Atricure, Inc.$34K
- Abbott$18K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$16K
- Boehringer Ingelheim$13K
- plus $11K from 25 others
Across 265 payments — averaging $3075.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$410K
- Atricure, Inc.$86K
- Abbott$81K
- Medtronic$80K
- Biosense Webster, Inc.$76K
- Irhythm Technologies, Inc.$46K
- plus $36K from 3 others
What the payments were for
- Consulting fees$80,05145%
- Speaking & faculty fees$52,20529%
- Travel & lodging$23,02413%
- Food & beverage$23,68113%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 115 | $44,997 |
| Boston Scientific | 286 | $43,798 |
| Atricure, Inc. | 63 | $33,737 |
| Abbott | 93 | $17,764 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 23 | $15,508 |
| Boehringer Ingelheim | 7 | $12,646 |
| EMD Serono, Inc. | 2 | $3,705 |
| Amgen | 8 | $1,657 |
| Genentech USA, Inc. | 1 | $1,615 |
| Biosense Webster, Inc. | 9 | $1,490 |
| ZOLL Respicardia, Inc. | 3 | $611 |
| Philips North America LLC | 5 | $305 |
| AOP Health US, LLC | 1 | $291 |
| Johnson & Johnson | 8 | $228 |
| Cardiva Medical, Inc. | 5 | $145 |
| Bardy Diagnostics, Inc. | 5 | $80 |
| Irhythm Technologies, Inc. | 3 | $77 |
| AstraZeneca | 4 | $48 |
| Novartis | 2 | $42 |
| Catheter Precision Inc. | 1 | $30 |
| Siemens Medical Solutions USA, Inc. | 1 | $26 |
| Esperion Therapeutics, Inc. | 2 | $24 |
| Lantheus Medical Imaging, Inc. | 1 | $24 |
| Baxter Healthcare | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $15 |
| Merck | 1 | $15 |
| Bayer | 1 | $13 |
| Angiodynamics, Inc. | 1 | $12 |
| Pfizer | 1 | $12 |
| Novo Nordisk | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$22,828
- LifeVest$14,850
- Farapulse$8,642
- ATRICLIP LAA EXCLUSION SYSTEM$7,139
- CLINICAL TRIAL PRODUCT$6,000
- AVEIR$5,394
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$5,203
- SYNERGY ABLATION SYSTEM$5,067
- WATCHMAN Access System$4,936
- WATCHMAN FLX$4,000
- GENERAL - THERAPIES$3,786
- AMPLATZER AMULET$2,129
- CryoConsole$1,834
- TECENTRIQ$1,615
- ALLURE$1,238
- Thermocool SF$1,089
- EMBLEM MRI S-ICD$868
- AFFERA MAPPING SYSTEM$804
- AMPLATZER Occluders$618
- remede System$611
How this compares
$178,960 in reported general payments places this provider in the 95th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
See all clinical cardiac electrophysiology providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 189 | $199,901 |
| XareltoRivaroxaban | 58 | $80,528 |
| SotalolSotalol Hcl | 67 | $1,272 |
| Warfarin Sodium | 136 | $1,242 |
| Metoprolol Succinate | 116 | $1,216 |
| Flecainide Acetate | 21 | $1,040 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 32 | $1,030 |
| Sotalol AfSotalol Hcl | 11 | $534 |
| ClopidogrelClopidogrel Bisulfate | 35 | $459 |
| Carvedilol | 51 | $457 |
| Amiodarone Hcl | 28 | $433 |
| Potassium Chloride | 21 | $247 |
| Furosemide | 37 | $202 |
| Amlodipine Besylate | 22 | $154 |
| Atorvastatin Calcium | 29 | $149 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $12 | $199,901189 claims |
| Johnson & JohnsonXarelto | $228 | $80,52858 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
Other clinical cardiac electrophysiology in Cincinnati
- Alexandru CosteaCincinnati$188K
- Dilesh PatelCincinnati$81K
- Marshall WinnerCincinnati$56K
- Emile DaoudCincinnati$46K
- Daniel PelchovitzCincinnati$43K
- Hemal ShahCincinnati$40K
- Wai TamCincinnati$40K
- Moses WananuCincinnati$38K
- Edward SchlossCincinnati$34K
- Andrew NollCincinnati$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.